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Data dredging, bias, or confounding
They can all get you into the BMJ and the Friday papers
On 4 October 2002, women who were moder›ate drinkers received good news: their risk ofbreast cancer was not raised, according to a
report in the Lancet that was widely covered by the
British media.1 The bad news was that smoking at an
early age was now implicated as a risk factor for breast
cancer. However, after they had enjoyed guilt›free
drinks (without cigarettes) for only a few days, on 13
November the message was reversed: alcohol did
increase the risk of breast cancer after all, but smoking
was declared innocent.2 The press release proclaimed
“Alcohol, tobacco and breast cancer: the definitive
answer.” A reader was driven to complain in the letters
page of the Guardian (14 November 2002): “So let me
get this right—alcohol’s no good anymore, and if you
smoked within five years of getting your periods, that’s
bad news too. Oh no, that was a couple of weeks ago;
smoking’s okay now . . . Do things stop being bad for us
if we just forget about them for a bit, do you think?”
This is a familiar story—so much so that in Bristol
we set our medical students the exercise of examining
the “health scare of the week” that appears each Friday,
generally from a study reported in the BMJ or Lancet.w1
Observational studies propose, RCTs dispose
The widespread perception that epidemiological studies
generate conflicting and often meaningless findingsw2
has received support from recent randomised control›
led trials, which have failed to confirm even apparently
robust findings from observational epidemiological
studies. The most topical of these relates to hormone
replacement therapy. In 1991 a meta›analysis of
epidemiological results relating the use of hormone
replacement therapy to the risk of coronary heart
disease concluded that it halved the risk, and that the
evidence was statistically robust (relative risk 0.50; 95%
confidence interval 0.43 to 0.56) and that “overall, the
bulk of the evidence strongly supports a protective effect
of estrogens that is unlikely to be explained by con›
founding factors.”3 Results from randomised controlled
trials were, however, very disappointing, with the first
large scale trial showing no benefit, confirmed in two
subsequent trials, resulting in a pooled odds ratio of 1.11
(0.96 to 1.30).4 The apparent cardioprotective effects of
hormone replacement therapy that had been found in
the observational epidemiology studies were over›
turned. Again, women were left wondering what they
should do.
A similar scenario had previously been played out
for the antioxidant vitamin â carotene. Promising epi›
demiological and laboratory findings led to a paper
published in 1981 in Nature entitled “Can dietary beta›
carotene materially reduce human cancer rates?”5
Cancers related to smoking seemed particularly tract›
able, and by 1990 the answer for lung cancer was a
clear yes: Walter Willett, reviewing the observational
epidemiological data, concluded that “Available data
thus strongly support the hypothesis that dietary caro›
tenoids reduce the risk of lung cancer.”6 Four years
later a large scale randomised controlled trial showed
an 18% increase (3% to 36%) in lung cancer in those
taking â carotene.7 Vitamin E and coronary heart
disease provided another example of observational
studies and randomised controlled trials failing to
reach the same conclusion.w3
“Eating fruit halves the risk of an early death” the
Independent claimedw4 in an excited response to a study
showing a strong inverse association between blood
vitamin C levels and mortality due to coronary heart
disease.8 A subsequent randomised controlled trial of a
vitamin supplement that raised blood vitamin C levels
by 15.7 ìmol/l found five year mortality due to coron›
ary heart disease unchanged (relative risk 1.06; 0.95 to
1.16),9 whereas the equivalent observational findings
for this increase in blood vitamin C were coronary
heart disease relative risks of 0.63 (0.49 to 0.84) in
women and 0.72 (0.61 to 0.86) in men (see fig A on
bmj.com). Again, the results from robust experiment
and fallible observation are clearly non›compatible.
This litany of failure has attracted considerable
popular comment. Medical journalist James Le Fanu
has proposed an extreme solution to this problem:
“The simple expedient of closing down most university
departments of epidemiology could both extinguish
this endlessly fertile source of anxiety mongering while
simultaneously releasing funds for serious research.”w5
Data dredging, biases, and confounding
It would seem wiser to attempt a better diagnosis of the
problem before prescribing Le Fanu’s solution. Data
dredging is thought by some to be the major problem:
epidemiologists have studies with a huge number of
variables and can relate them to a large number of out›
comes, with one in 20 of the associations examined
being “statistically significant” and thus acceptable for
publication in medical journals.w6 The misinterpretation
of a P < 0.05 significance test as meaning that such find›
ings will be spurious on only 1 in 20 occasions unfortu›
nately continues. When a large number of associations
can be looked at in a dataset where only a few real asso›
ciations exist, a P value of 0.05 is compatible with the
large majority of findings still being false positives.w7
These false positive findings are the true products of
data dredging, resulting from simply looking at too
many possible associations. One solution here is to be
much more stringent with “significance” levels, moving
to P < 0.001 or beyond, rather than P < 0.05.w7
Selection and information biases also need to be
considered. Selection bias could produce a study data›
base in which a given exposure is related to a variety of
characteristics that increase (or decrease) risk of
disease, where such associations are not apparent in
the general population. Information biases also arise.
For example, some people like to complain and will, if
asked, complain both about life’s experiences (such as
stress) and also subjective health outcomes (such as
having chest pain). An association between the two
would lead to the inference that life stressors lead to
angina, but in fact the two are simply related by a pro›
clivity to complain, as evidenced by the finding that
there is no association between reporting life stressors
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and objective, as opposed to subjective, indicators of
coronary heart disease.10
By far the most likely cause of spurious association is
confounding—where one factor that is not itself causally
related to disease is associated with a range of other fac›
tors that do increase disease risk. Women who use
hormone replacement therapy may be less likely to be
smokers, more likely to exercise regularly, and less likely
to be poor, all of which reduce the risk of coronary heart
disease (see fig B on bmj.com). Associations reported in
observational studies but not confirmed in randomised
controlled trials tend to be of exposures that are related
to many socioeconomic and behavioural measures that
are in turn related to disease. As with bias, increasing the
significance level provides no protection against being
misled by confounded associations.
The inadequately recognised truth is that we live in
an associational world—people who are disadvantaged
in one regard tend to be disadvantaged in other regards,
since the forces that structure life chances and
experience tend to ensure that some folk get the worst of
all things. We showed this by producing a pairwise
correlation matrix of 133 physical examination and
laboratory assay variables (8778 correlations) derived
from a study of over 4000 older women.w8 This would be
expected to yield 88 “significant” chance associations at
the P < 0.01 level. In fact over 3000 such correlations
were observed with a P value < 0.01. In many ways it is
more remarkable when things don’t “significantly”
correlate with each other than when they do.
A standard argument is that hypotheses built on
good scientific understanding of pathogenesis are
unlikely to be spurious, but unfortunately it is generally
easy to find a biologically plausible mechanism to
“explain” each association.w9 Furthermore, it is seldom
recognised how poorly the standard statistical tech›
niques “control” for confounding, given the limited
range of confounders measured in many studies and
the inevitable substantial degree of measurement error
in assessing the potential confounders.w9 w10
What can be done about confounding?
Where possible, associations should be replicated in
databases in which the potential confounding structure
differs from the initial study. In different countries expo›
sures such as self reported stress, diet, or birth
dimensions, for example, may be related in different
ways to socioeconomic circumstances and socio›
economically patterned causes of disease. Finding the
same association within different populations gives
some protection against being misled by confounding.
Specificity of associations between exposure and
diseases is also helpful, as most diseases have only a
finite number of causes. When exposures are related in
a promiscuous way with a wide variety of outcomes,
confounding by socially patterned behavioural and
environmental factors is likely. Early on in the
hormone replacement therapy debate, Diana Petitti
pointed out that hormone replacement therapy appar›
ently protected against accidental and violent deaths in
observational studies as much as against coronary
heart disease—and that given the lack of a plausible
biological link between hormone replacement therapy
and accidental or violent death, both associations may
have been confounded.11 This suggestion was later
confirmed by the randomised controlled trials.4
Further measures include improving study design by
measuring confounders better and thus allowing for a
greater degree of statistical control. This may require
carrying out more measurements on a smaller number
of participants.w11 Sensitivity analyses should be carried
out to model the degree to which measurement error in
confounders could have left residual confoundingw12 w13
and should be a necessary part of the statistical
reporting of study results. A gift to epidemiology from
modern genomics is the potential for using functional
genetic polymorphisms that mimic the effects of
environmental exposures to test exposure›disease
relationships. There is very little opportunity when alle›
les segregate—effectively a random process—for social
and behavioural factors to confound the resulting
polymorphism›disease associations.12 w14
Finally, the findings in observational studies of indi›
viduals should be related to the differences in risk of
disease observed between populations, and within
populations over time, as only those exposures which
fit coherently into this scheme are likely to be
important causes of disease.
Of course all our recommendations should be sus›
pended once a year, to allow the Christmas issue of the
BMJ to continue with its tradition of making the festive
time a merrily data dredged, biased, and confounded
one. Also remember that dredging, now disparaged,
was the technique by which pearls were harvested from
oysters. Among data dredged observations will reside
new and precious associations: the only problem is
deciding which ones should be gathered and used.
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